PHARMACIE BERGMAN
0465.419.559 · rovalta.com · 26/09/2026
OPENING OF BANKRUPTCY
PHARMACIE BERGMAN
Company — Opening of bankruptcy.
Financial year 2024 · Closed on 31/12/2024
Net result-82,7 k €-186,5 %over 1 year
Gross margin11,6 k €-92,8 %over 1 year
Equity-61,7 k €-393,4 %over 1 year
Workforce0,8 ETP+33,3 %over 1 year
Overview
Identity
Source · BCE/KBOPHARMACIE BERGMAN is a Private company with limited liability incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ganshoren. It employs on average 0,8 ETP workers (FTE).
- Legal situation
- Opening of bankruptcy
- BCE/KBO no. / VAT
- BE 0465.419.559
- Incorporation
- 10/02/1999
- Legal form
- Private company with limited liability
- Registered office
- Drève de Rivieren 85 box 49
1083 Ganshoren · BruxellesSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2024
- Average workforce
- 0,8 ETP
Activities (NACE)
Joint committees (1)
- 313
Contacts
3 public details availableLog in to view
Signals
Healthy social debts
Financials
Source · NBB, 19 filingsTrend over 19 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 11,6 k € | -92.8% | 161,7 k € | -34.6% | 247,2 k € | -7.5% | 267,3 k € | +29.3% | 206,7 k € |
| EBITDA | -74,2 k € | -177% | 96,6 k € | -55.1% | 214,8 k € | -11.2% | 242 k € | +32.1% | 183,2 k € |
| Operating result | -75,8 k € | -179% | 95,8 k € | -55.3% | 214,2 k € | -11.1% | 241 k € | +36.6% | 176,5 k € |
| Net result | -82,7 k € | -187% | 95,6 k € | -42.4% | 166 k € | -10.5% | 185,5 k € | +49.8% | 123,9 k € |
| Balance sheet | |||||||||
| Equity | -61,7 k € | -393% | 21 k € | -96.6% | 617,5 k € | +22.9% | 502,5 k € | +31.6% | 382 k € |
| Total assets | 719,2 k € | -38.5% | 1,2 M € | +55.5% | 752,3 k € | +38.6% | 542,6 k € | +0.1% | 542,2 k € |
| Cash | 107 k € | -19.4% | 132,7 k € | -76.7% | 570,8 k € | +34.3% | 425,1 k € | +2.2% | 415,7 k € |
| Debts | 780,8 k € | -32.0% | 1,1 M € | +752% | 134,8 k € | +236% | 40,1 k € | -75.0% | 160,2 k € |
| Other | |||||||||
| Workforce | 0,8 ETP | +33.3% | 0,6 ETP | 0.0% | 0,6 ETP | +20.0% | 0,5 ETP | 0.0% | 0,5 ETP |
Board of directors
Source · NBB, accounts to 31/12/20241 active · 7 ended
Active mandates
Michaël WILLEMS
ActiveEnded mandates
Daniel BERGMAN
EndedDANIEL BERGMAN
EndedDANIEL BERGMAN
EndedMichael Willems
EndedOther companies at this address
Drève de Rivieren 85 1083 Ganshoren| Company | CBE no. |
|---|---|
A.C.P. I DREVE RIVIEREN 85● Active | 0850.115.720 |
Marnixclub● Active | 0410.231.410 |
REFORM PHARMA● Active | 1042.257.278 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/11/2025 | 02/08/2024 | 05/06/2023 | 30/08/2022 | 02/08/2021 | 09/10/2020 |
| General meeting | 07/06/2025 | 01/06/2024 | 03/06/2023 | 04/06/2022 | 05/06/2021 | 06/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 07/06/2025 | 26/11/2025 | French | |
| Abridged model | 31/12/2023 | 01/06/2024 | 02/08/2024 | French | |
| Abridged model | 31/12/2022 | 03/06/2023 | 05/06/2023 | French | |
| Abridged model | 31/12/2021 | 04/06/2022 | 30/08/2022 | French | |
| Abridged model | 31/12/2020 | 05/06/2021 | 02/08/2021 | French | |
| Abridged model | 31/12/2019 | 06/06/2020 | 09/10/2020 | French | |
| Abridged model | 31/12/2018 | 01/06/2019 | 30/08/2019 | French | |
| Abridged model | 31/12/2017 | 02/06/2018 | 31/08/2018 | French | |
| Abridged model | 31/12/2016 | 03/06/2017 | 27/07/2017 | French | |
| Abridged model | 31/12/2015 | 04/06/2016 | 30/08/2016 | French | |
| Abridged model | 31/12/2014 | 06/06/2015 | 27/08/2015 | French | |
| Abridged model | 31/12/2013 | 07/06/2014 | 18/06/2014 | French | |
| Abridged model | 31/12/2012 | 01/06/2013 | 30/07/2013 | French | |
| Abridged model | 31/12/2011 | 02/06/2012 | 20/08/2012 | French | |
| Abridged model | 31/12/2010 | 04/06/2011 | 14/07/2011 | French | |
| Abridged model | 31/12/2009 | 15/06/2010 | 29/09/2010 | French | |
| Abridged model | 31/12/2008 | 03/06/2009 | 30/06/2009 | French | |
| Abridged model | 31/12/2007 | 09/06/2008 | 20/08/2008 | French | |
| Abridged model | 31/12/2006 | 03/06/2007 | 04/07/2007 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 7 ended
Active mandates
Michaël WILLEMS
ActiveEnded mandates
Daniel BERGMAN
EndedDANIEL BERGMAN
EndedDANIEL BERGMAN
EndedMichael Willems
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-82,7 k €↓
- 2024Name changeBERGMAN PHARMACIE
- 2023Annual accounts 202395,6 k €↓
- 2022Annual accounts 2022166 k €↓
- 2021Annual accounts 2021185,5 k €↑
- 2021Name changePHARMACIE BERGMAN
- 2020Annual accounts 2020123,9 k €↑
- 2019Annual accounts 201986,4 k €↑
- 2018Annual accounts 201876,2 k €↑
- 2017Annual accounts 201727,2 k €↓
- 2016Annual accounts 201689 k €↓
- 2015Annual accounts 2015103,3 k €↑
- 2014Annual accounts 201451,3 k €↑
- 2013Annual accounts 201329,8 k €↓
- 2012Annual accounts 201235,2 k €↓
- 2011Annual accounts 201150,5 k €↑
- 2010Annual accounts 201044,2 k €↑
- 2009Annual accounts 20096,5 k €↓
- 2008Annual accounts 20089,4 k €↓
- 2007Annual accounts 200712,3 k €↑
- 2006Annual accounts 20066,2 k €
- 10/02/1999IncorporationPrivate company with limited liability